Publications
Detailed Information
Clinical results of stereotactic body frame based fractionated radiation therapy for primary or metastatic thoracic tumors
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yoon, Sang Min | - |
dc.contributor.author | Choi, Eun Kyung | - |
dc.contributor.author | Lee, Sang-Wook | - |
dc.contributor.author | Yi, Byong Yong | - |
dc.contributor.author | Ahn, Seung Do | - |
dc.contributor.author | Shin, Seong Soo | - |
dc.contributor.author | Park, Heon Joo | - |
dc.contributor.author | Kim, Su Ssan | - |
dc.contributor.author | Park, Jin-Hong | - |
dc.contributor.author | Song, Si Yeol | - |
dc.contributor.author | Park, Charn Il | - |
dc.contributor.author | Kim, Jong Hoon | - |
dc.date.accessioned | 2010-01-08T08:28:25Z | - |
dc.date.available | 2010-01-08T08:28:25Z | - |
dc.date.issued | 2006-11-23 | - |
dc.identifier.citation | Acta Oncol. 2006;45(8):1108-14. | en |
dc.identifier.issn | 0284-186X (Print) | - |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17118847 | - |
dc.identifier.uri | https://hdl.handle.net/10371/29072 | - |
dc.description.abstract | The aim of this study was to evaluate the treatment outcomes of stereotactic body radiation therapy for treating primary or metastatic thoracic tumors using a stereotactic body frame. Between January 1998 and February 2004, 101 lesions from 91 patients with thoracic tumors were prospectively reviewed. A dose of 10-12 Gy per fraction was given three to four times over consecutive days to a total dose of 30-48 Gy (median 40 Gy). The overall response rate was 82%, with 20 (22%) complete responses and 55 (60%) partial responses. The one- and two-year local progression free survival rates were 90% and 81%, respectively. The patients who received 48 Gy showed a better local tumor control than those who received less than 48 Gy (Fisher exact test; p = 0.004). No pulmonary complications greater than a RTOG toxicity criteria grade 2 were observed. The experience of stereotactic body frame based radiation therapy appears to be a safe and promising treatment modality for the local management of primary or metastatic lung tumors. The optimal total dose, fractionation schedule and treatment volume need to be determined after a further follow-up of these results. | en |
dc.language.iso | en | - |
dc.publisher | Taylor & Francis | en |
dc.subject | Adolescent | en |
dc.subject | Adult | en |
dc.subject | Aged | en |
dc.subject | Aged, 80 and over | en |
dc.subject | Child | en |
dc.subject | Dose Fractionation | en |
dc.subject | Female | en |
dc.subject | Humans | en |
dc.subject | Male | en |
dc.subject | Middle Aged | en |
dc.subject | Positron-Emission Tomography | en |
dc.subject | Radiosurgery/*instrumentation | en |
dc.subject | Survival Rate | en |
dc.subject | Thoracic Neoplasms/*surgery | en |
dc.subject | Treatment Outcome | en |
dc.title | Clinical results of stereotactic body frame based fractionated radiation therapy for primary or metastatic thoracic tumors | en |
dc.type | Article | en |
dc.contributor.AlternativeAuthor | 윤상민 | - |
dc.contributor.AlternativeAuthor | 최은경 | - |
dc.contributor.AlternativeAuthor | 이상욱 | - |
dc.contributor.AlternativeAuthor | 이병용 | - |
dc.contributor.AlternativeAuthor | 안승도 | - |
dc.contributor.AlternativeAuthor | 신성수 | - |
dc.contributor.AlternativeAuthor | 박헌주 | - |
dc.contributor.AlternativeAuthor | 박진홍 | - |
dc.contributor.AlternativeAuthor | 송시열 | - |
dc.contributor.AlternativeAuthor | 박찬일 | - |
dc.contributor.AlternativeAuthor | 김종훈 | - |
dc.identifier.doi | 10.1080/02841860600812685 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.